Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Thorac Cardiovasc Surg ; 67(1): 28-36, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-29232733

RESUMEN

BACKGROUND: The increasing complexity of congenital cardiac surgery has resulted in the increased use of extracorporeal membrane oxygenation (ECMO) support for children who cannot be weaned from cardiopulmonary bypass. The purpose of this research was to assess the mortality and morbidity in children requiring ECMO support after the repair of congenital heart defects (CHDs). METHODS: The hospital records of all patients with CHD who required ECMO after a cardiac surgical procedure between January 2001 and December 2016 were retrospectively reviewed. Various outcomes were reported and tested for any association with hospital death. RESULTS: A total of 113 children required ECMO for cardiopulmonary support after congenital cardiac surgery; 88 (77.9%) were placed on ECMO in the operating room. Median age of the patients was 3 months (range, 4 days-15 years) and median weight was 3.5 kg (range, 2.2-42.5). Forty-two (37.2%) survived to hospital discharge. In children with single-ventricle physiology, survival to discharge was 37.3% (19/51 patients) and for biventricular physiology, it was 37.1% (23/62 patients). Univariate analysis revealed number of days on ECMO support, renal failure, and stroke as risk factors for hospital mortality, while age and cross-clamp time were found to be statistically nonsignificant. CONCLUSION: Satisfactory results can be achieved in pediatric patients by using ECMO support for postoperative cardiac and pulmonary failure refractory to medical management. Prolonged ECMO support, renal failure, and stroke are risk of mortality.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Puente Cardiopulmonar/efectos adversos , Oxigenación por Membrana Extracorpórea , Cardiopatías Congénitas/cirugía , Insuficiencia Cardíaca/terapia , Insuficiencia Respiratoria/terapia , Adolescente , Factores de Edad , Procedimientos Quirúrgicos Cardíacos/mortalidad , Puente Cardiopulmonar/mortalidad , Niño , Preescolar , Oxigenación por Membrana Extracorpórea/efectos adversos , Oxigenación por Membrana Extracorpórea/mortalidad , Cardiopatías Congénitas/mortalidad , Cardiopatías Congénitas/fisiopatología , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/mortalidad , Insuficiencia Cardíaca/fisiopatología , Mortalidad Hospitalaria , Humanos , Lactante , Recién Nacido , Recuperación de la Función , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/mortalidad , Insuficiencia Respiratoria/fisiopatología , Estudios Retrospectivos , Factores de Riesgo , Arabia Saudita , Factores de Tiempo , Resultado del Tratamiento
2.
Phytother Res ; 30(3): 412-7, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26648323

RESUMEN

The present study was carried out to evaluate anti-Helicobacter pylori and its associated urease activity of labdane diterpenoids isolated from Andrographis paniculata. A molecular docking analysis was performed by using ArgusLab 4.0.1 software. The results obtained indicate that compound A possesses strong inhibition to H. pylori, 28 ± 2.98 (minimum inhibitory concentration, 9 µg/mL), and its urease, 85.54 ± 2.62% (IC50 , 20.2 µg/mL). Compounds B, C, and D also showed moderate inhibition to H. pylori and its urease. The obtained results were in agreement with the molecular docking analysis of compounds. The phytochemicals under investigation were found to be promising antibacterial agents. Moreover, the isolated compounds can be considered as a resource for searching novel anti-H. pylori agents possessing urease inhibition.


Asunto(s)
Andrographis/química , Antibacterianos/farmacología , Diterpenos/farmacología , Helicobacter pylori/efectos de los fármacos , Extractos Vegetales/farmacología , Ureasa/antagonistas & inhibidores , Antibacterianos/aislamiento & purificación , Proteínas Bacterianas/antagonistas & inhibidores , Diterpenos/aislamiento & purificación , Helicobacter pylori/enzimología , Helicobacter pylori/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Simulación del Acoplamiento Molecular , Extractos Vegetales/química
3.
J Enzyme Inhib Med Chem ; 29(1): 7-11, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23356406

RESUMEN

Abstract A series of asymmetric indole curcumin analogs were synthesized and evaluated as possible inhibiters of pro-inflammatory enzymes such as COX-2, pro-inflammatory cytokines as TNF-α and IL-6, trypsin and ß-glucuronidase. They were also tested for antioxidant activities. The results showed that compounds 5e and 5h were found to be the most potent inhibitors of COX-2 (83.33%, 82.50%) and ß-glucuronidase (67.80%, 64.12%). All the synthesized compounds exhibited promising activity against IL-6 in a range of 71-100% at 10 µM concentration. Compounds 5f, 5h, 5e, 5c and 5d showed significant inhibition against TNF-α (28-51%) and IL-6 (87-98%) with low toxicity (45-51%) against CCK-8 cells. With few exceptions, all other compounds were found to be good to excellent inhibitors of IL-6 and moderate inhibitors of TNF-α; however, the toxicity profiles of these compounds need to be ameliorated in further optimization studies. Amongst the tested compounds, 5c, 5b, 5j and 5g were found to possess excellent reducing activity and 5b, 5c and 5h were moderate DPPH (1,1-diphenyl-2-picryl hydrazine) radical scavengers.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Curcumina/análogos & derivados , Línea Celular , Curcumina/farmacología , Inhibidores de la Ciclooxigenasa 2/farmacología , Citocinas/antagonistas & inhibidores , Humanos , Mediadores de Inflamación/antagonistas & inhibidores , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Inhibidores de Tripsina/farmacología
4.
Bioorg Med Chem Lett ; 23(3): 912-6, 2013 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-23290048

RESUMEN

A series of novel pyrazole integrated benzophenones (9a-j) have been designed, synthesized from 1-methyl-5-(2,4,6-trimethoxy-phenyl)-1H-pyrazole 6. The structures of the regioisomers 6 and 7 were determined by 2D (1)H-(1)H COSY, (1)H-(13)C HSQC and (1)H-(13)C HMBC experiments. The newly synthesized compounds (9a-j) were evaluated for in vivo anti-inflammatory activity by carrageenan paw edema in rats and in vitro COX-1/COX-2 inhibition and antioxidant potential. Among the synthesized compounds, compounds 9b, 9d and 9f, were found to be active anti-inflammatory agents in addition to having potent antioxidant activity.


Asunto(s)
Antiinflamatorios/síntesis química , Antioxidantes/síntesis química , Benzofenonas/síntesis química , Benzofenonas/farmacología , Diseño de Fármacos , Pirazoles/síntesis química , Animales , Antiinflamatorios/química , Antiinflamatorios/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Benzofenonas/química , Células Cultivadas , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Pirazoles/química , Pirazoles/farmacología , Ratas , Estereoisomerismo
5.
Appl Biochem Biotechnol ; 195(1): 253-263, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36070167

RESUMEN

In this study, a novel Schiff base was synthesized which comprises a core moiety of 2-butyl-4-chloro imidazole. The ligand was synthesized by the reaction between the carbonyl compound 4-[(2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl) methyl] benzoate and primary hydrazine compounds such as 2,4-dinitrophenylhydrazine in the presence of an alcoholic solvent and an acid catalyst. The synthesized Schiff base ligand is characterized by mass and spectral analysis including NMR. The appearance of extended conjugation of the π-electrons system between active 2-butyl-4-chloro imidazole moieties with nitro substituted phenyl ring. The ligands are assessed for an antibacterial activity for Escherichia coli and Staphylococcus aureus to evaluate the inhibition potential by MIC and well diffusion method. The biological activity of the ligand has shown a significant property against the Gram-negative bacterium, E. coli, and Gram-positive bacterium, S. aureus of about 27 mm and 28 mm of inhibitory action, respectively. This study paves the way for the development of novel antimicrobial agents for emerging clinical pathogens.


Asunto(s)
Antiinfecciosos , Bases de Schiff , Bases de Schiff/farmacología , Bases de Schiff/química , Escherichia coli , Staphylococcus aureus , Ligandos , Antiinfecciosos/farmacología , Antiinfecciosos/química , Antibacterianos/química , Imidazoles/farmacología , Imidazoles/química , Pruebas de Sensibilidad Microbiana
6.
Org Biomol Chem ; 8(6): 1259-70, 2010 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-20204191

RESUMEN

Elimination of suitable leaving groups from 3-substituted indoles under basic or acidic conditions readily provides alkylideneindolenine intermediates that may react with a large variety of nucleophilic reagents. This article highlights some recent developments of this synthetic approach for the preparation of functionalized indole derivatives.


Asunto(s)
Alcanos/química , Indoles/química , Indoles/síntesis química , Descubrimiento de Drogas , Indicadores y Reactivos/química , Indoles/farmacología
7.
Chem Commun (Camb) ; 53(4): 677-696, 2017 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-27942626

RESUMEN

Pillar[n]arenes are a new class of synthetic supramolecular macrocycles streamlined by their particular pillar-shaped architecture which consists of an electron-rich cavity and two fine-tuneable rims. The ease and diversity of the functionalization of the two rims open possibilities for the design of new architectures, topological isomers, and scaffolds. Significantly, this emerging class of macrocyclic receptors offers a unique platform for biological purposes. This review article covers the most recent contributions from the pillar[n]arene field in terms of artificial membrane transport systems, controlled drug delivery systems, biomedical imaging, biosensors, cell adhesion, fluorescent sensing, and pesticide detection based on host-guest interactions. The review also uniquely describes the properties of sub-units that make pillar[n]arenes suitable for biological applications and it provides a detailed outline for the design of new innovative pillar-like structures with specific properties to open up a new avenue for pillar[n]arene chemistry.

8.
J Tradit Complement Med ; 6(4): 355-361, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27774419

RESUMEN

The present study was carried out to evaluate in vivo and in vitro anti-inflammatory potential of selected medicinal plants used in Indian traditional medication. The sequentially extracted plant samples as, Cissus quadrangularis, Plumbago zeylanica, Terminalia bellarica and Terminalia chebula in water, ethanol and hexane were evaluated in-vitro for COX-1 and 2 inhibitory and antioxidant activities. The in vivo anti-inflammatory activity of selected samples showing promising COX-2 inhibition was assessed using carrageenan and Phorbol Myristate Acetate (PMA) induced mice edema animal model. The results obtained reveals that most of the plants were found to inhibit COX-2 activity as compared to COX-1. It was observed that the extracts of T. bellarica (73.34 %) and T. chebula (74.81 %) showed significant COX-2 selective inhibition as compared to other samples. The ethanol extract of the selected plants demonstrated effective DPPH, OH and superoxide radical scavenging activity. In vivo anti-inflammatory study shows that, T. bellarica and T. chebulla had a significant impact on inhibition of edema formation. The cytotoxicity evaluation study of ethanolic fraction of selected medicinal plants indicates that the selected samples have no effect on cell viability. HPTLC fingerprint of flavonoids of the selected samples was also prepared as a measure of quality control. The results obtained may be useful in strengthening the standardization of the selected botanicals. Moreover the selected plants can be considered as a resource for searching novel anti-inflammatory agents possessing COX-2 inhibition.

9.
J Tradit Complement Med ; 4(4): 253-7, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25379467

RESUMEN

The present study was carried out to evaluate the anticancer, antioxidant, and possible anti-inflammatory properties of diverse medicinal plants frequently used in Indian traditional medication. The selected botanicals such as Soymida fembrifuga (Roxb.) A. Juss. (Miliaceae), Tinospora cordifolia (Willd.) Miers. (Menispermaceae), Lavandula bipinnata (L.) O. Ktze. (Lamiaceae), and Helicteres isora L. (Sterculiaceae) extracted in different solvents were evaluated for their in vitro anticancer and antioxidant activities. The results obtained indicate that H. isora has potent cytotoxic activity toward the selected cancer cells such as HeLa-B75 (34.21 ± 0.24%), HL-60 (30.25 ± 1.36%), HEP-3B (25.36 ± 1.78%), and PN-15 (29.21 ± 0.52%). Interestingly, the selected botanicals selectively inhibited cyclooxygenase-2 (COX-2) more than (COX-1), which are the key enzymes implicated in inflammation. COX-2 inhibition was observed to be in the range of 19.66-49.52% as compared to COX-1 inhibition (3.93-19.61%). The results of the antioxidant study revealed that the selected plants were found to be effective 1,1-diphenyl-2-picrylhydrazyl (DPPH), hydroxyl (OH), and superoxide radical (SOR) scavenging agents. High-performance thin layer chromatography (HPTLC) fingerprint of flavonoids was used as a measure of quality control of the selected plant samples. The results of the present findings strengthen the potential of the selected plants as a resource for the discovery of novel anticancer, anti-inflammatory, and antioxidant agents.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA